- Home
- GLRE vs TCMD Comparison
GLRE vs TCMD Comparison
Compare GLRE & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GLRE | TCMD |
|---|---|---|
| Founded | 2004 | 1995 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 513.1M | 533.5M |
| IPO Year | 2007 | 2016 |
Fundamental Metrics
Financial Performance| Metric | GLRE | TCMD |
|---|---|---|
| Price | $16.06 | $26.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $36.00 |
| AVG Volume (30 Days) | 134.3K | ★ 188.3K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.00 | 17.14 |
| EPS | ★ 1.05 | N/A |
| Revenue | ★ $729,777,000.00 | N/A |
| Revenue This Year | N/A | $11.60 |
| Revenue Next Year | N/A | $9.14 |
| P/E Ratio | $15.29 | ★ N/A |
| Revenue Growth | ★ 4.85 | N/A |
| 52 Week Low | $11.57 | $9.42 |
| 52 Week High | $19.39 | $37.77 |
Technical Indicators
Market Signals| Indicator | GLRE | TCMD |
|---|---|---|
| Relative Strength Index (RSI) | 45.89 | 59.28 |
| Support Level | $13.77 | $25.79 |
| Resistance Level | $17.02 | $27.67 |
| Average True Range (ATR) | 0.38 | 0.88 |
| MACD | 0.14 | 0.11 |
| Stochastic Oscillator | 78.84 | 89.47 |
Price Performance
Historical ComparisonAbout GLRE Greenlight Capital Re Ltd.
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.